APRICOXIB Cyclooxygenase-2 (COX-2) Inhibitor Oncolytic

被引:0
|
作者
Edelman, Martin J. [1 ]
机构
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
CS-706; R-109339; TG-01; TP-1001; TP-2001; METASTATIC BREAST-CANCER; CELL LUNG-CANCER; DOUBLE-BLIND; CARDIOVASCULAR EVENTS; COVALENT BINDING; PHASE-II; CELECOXIB; EXPRESSION; ROFECOXIB; CS-706;
D O I
10.1358/dof.2011.036.07.1608943
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Overexpression of cyclooxygenase-2 (COX-2) has been implicated as a tumor-initiating and -promoting event for a number of common solid tumors, including lung, breast and colon cancer. Considerable epidemiological evidence supports COX-2 inhibition as a method of chemoprevention. Inhibition of COX-2 in laboratory models has been demonstrated to be antineoplastic both by itself and in combination with cytotoxic and targeted agents. Apricoxib is a novel, potent and selective inhibitor of COX-2 currently under development as an anti-cancer agent, as well as an analgesic. This review discusses the pharmacology, preclinical and clinical results with apricoxib, focusing on its potential use in oncology.
引用
收藏
页码:503 / 509
页数:7
相关论文
共 50 条
  • [41] The role of cyclooxygenase-2 (COX-2) in inflammatory bone resorption
    Coon, David
    Gulati, Ajay
    Cowan, Cameron
    He, Jianing
    JOURNAL OF ENDODONTICS, 2007, 33 (04) : 432 - 436
  • [42] Radiotracers for Molecular Imaging of Cyclooxygenase-2 (COX-2) Enzyme
    Tietz, O.
    Marshall, A.
    Wuest, M.
    Wang, M.
    Wuest, F.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (35) : 4350 - 4369
  • [43] Cyclooxygenase-2 (COX-2) expression in Barrett's esophagus
    Kandil, HM
    Tanner, G
    Smalley, W
    Halter, S
    Radhika, A
    Shattuck-Brandt, R
    DuBois, RN
    GASTROENTEROLOGY, 1999, 116 (04) : A431 - A431
  • [44] Cyclooxygenase-2 (COX-2) Is Essential for Colorectal Anastomotic Healing
    Reisinger, Kostan
    Schellekens, Dirk H.
    von Meyenfeldt, Maarten
    Poeze, Martijn
    GASTROENTEROLOGY, 2013, 144 (05) : S719 - S719
  • [45] Cyclooxygenase-2 (COX-2) enzyme in tumor biology and therapy
    Milas, L
    Mason, KA
    Raju, U
    Ang, KK
    PROGRESS IN RADIO-ONCOLOGY VII, PROCEEDINGS, 2001, : 547 - 555
  • [46] Cyclooxygenase-2 (COX-2) - A therapeutic target in liver cancer?
    Breinig, Marco
    Schirmacher, Peter
    Kern, Michael Andre
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (32) : 3305 - 3315
  • [47] Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
    G. Aparicio Gallego
    S. Díaz Prado
    P. Jiménez Fonseca
    R. García Campelo
    J. Cassinello Espinosa
    L. M. Antón Aparicio
    Clinical and Translational Oncology, 2007, 9 : 694 - 702
  • [48] Cyclooxygenase-2 (COX-2) overexpression in childhood brain tumors
    Bodey, Bela
    Siegel, Stuart E.
    Kaiser, Hans E.
    CANCER RESEARCH, 2006, 66 (08)
  • [49] Expression of cyclooxygenase-2 (COX-2) in experimental glaucoma in rats
    Kwong, JM
    Caprioli, J
    Lam, TT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U227 - U227
  • [50] The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferative rate of retinoblastoma cell lines
    Souza, JP
    Correa, ZM
    Marshall, JCA
    Coutinho, AB
    Martins, MC
    Burneir, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46